BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34586059)

  • 21. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High incidence of multisystem inflammatory syndrome and other autoimmune diseases after SARS-CoV-2 infection compared to COVID-19 vaccination in children and adolescents in south central Europe.
    Bizjak M; Emeršič N; Zajc Avramovič M; Barbone F; Ronchese F; Della Paolera S; Conversano E; Amoroso S; Vidoni M; Vesel Tajnšek T; Mlakar G; Berce V; Markelj G; Plankar Srovin T; Golli T; Osredkar D; Koren Jeverica A; Toplak N; Pokorn M; Avšič Županc T; Ihan A; Fafangel M; Taddio A; Avčin T
    Clin Exp Rheumatol; 2023 May; 41(5):1183-1191. PubMed ID: 36377567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.
    Epsi NJ; Richard SA; Lindholm DA; Mende K; Ganesan A; Huprikar N; Lalani T; Fries AC; Maves RC; Colombo RE; Larson DT; Smith A; Chi SW; Maldonado CJ; Ewers EC; Jones MU; Berjohn CM; Libraty DH; Edwards MS; English C; Rozman JS; Mody RM; Colombo CJ; Samuels EC; Nwachukwu P; Tso MS; Scher AI; Byrne C; Rusiecki J; Simons MP; Tribble D; Broder CC; Agan BK; Burgess TH; Laing ED; Pollett SD;
    Clin Infect Dis; 2023 Feb; 76(3):e439-e449. PubMed ID: 35608504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Suspected Case of Multisystem Inflammatory Disease in Children Following COVID-19 Vaccination: A Case Report and Systematic Literature Review.
    Lee JS; Cho KS; Choe YJ
    Pediatr Infect Dis J; 2022 Nov; 41(11):e456-e460. PubMed ID: 36102702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    Stowe J; Miller E; Andrews N; Whitaker HJ
    PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with messenger RNA vaccines against COVID-19 in adolescents with a history of multisystem inflammatory syndrome: a case series.
    Curtti T; Agrimbau Vázquez J; Yori S; Kantarovsky A; Torolla J; Di Santo M; Hammermüller E; Urrutia L; Parra A
    Arch Argent Pediatr; 2023 Jun; 121(3):e202202757. PubMed ID: 36194695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-​Barré Syndrome Associated with COVID-19 Vaccination.
    Shao SC; Wang CH; Chang KC; Hung MJ; Chen HY; Liao SC
    Emerg Infect Dis; 2021 Dec; 27(12):3175-3178. PubMed ID: 34648420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.
    Chemaitelly H; Ayoub HH; AlMukdad S; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
    Lancet Microbe; 2022 Dec; 3(12):e944-e955. PubMed ID: 36375482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022.
    Zambrano LD; Newhams MM; Olson SM; Halasa NB; Price AM; Orzel AO; Young CC; Boom JA; Sahni LC; Maddux AB; Bline KE; Kamidani S; Tarquinio KM; Chiotos K; Schuster JE; Cullimore ML; Heidemann SM; Hobbs CV; Nofziger RA; Pannaraj PS; Cameron MA; Walker TC; Schwartz SP; Michelson KN; Coates BM; Flori HR; Mack EH; Smallcomb L; Gertz SJ; Bhumbra SS; Bradford TT; Levy ER; Kong M; Irby K; Cvijanovich NZ; Zinter MS; Bowens C; Crandall H; Hume JR; Patel MM; Campbell AP; Randolph AG;
    Clin Infect Dis; 2023 Feb; 76(3):e90-e100. PubMed ID: 35924406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Insight into Multisystem Inflammatory Syndrome in Adults Associated with Recent SARS-COV-2 Infection: A Case Series.
    Agarwal A; Jakhar R; Sharma A; Sharma A; Agarwal A; Kumari A
    J Assoc Physicians India; 2023 Aug; 71(8):11-12. PubMed ID: 37651238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
    Laing ED; Weiss CD; Samuels EC; Coggins SA; Wang W; Wang R; Vassell R; Sterling SL; Tso MS; Conner T; Goguet E; Moser M; Jackson-Thompson BM; Illinik L; Davies J; Ortega O; Parmelee E; Hollis-Perry M; Maiolatesi SE; Wang G; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Lindrose AR; Duplessis CA; Tribble DR; Malloy AMW; Burgess TH; Pollett SD; Olsen CH; Broder CC; Mitre E
    Emerg Infect Dis; 2022 Apr; 28(4):828-832. PubMed ID: 35203111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.
    Hatfield KM; Baggs J; Wolford H; Fang M; Sattar AA; Montgomery KS; Jin S; Jernigan J; Pilishvili T
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S147-S154. PubMed ID: 35856635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serologic Status According Severe Acute Respiratory Syndrome Coronavirus 2 in Patients After Orthotopic Heart Transplantation.
    Kuczaj A; Przybyłowski P
    Transplant Proc; 2022 May; 54(4):901-904. PubMed ID: 35414422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS).
    Ludwikowska KM; Popiel A; Matkowska-Kocjan A; Biela M; Wójcik M; Szenborn F; Wielgos K; Pielka-Markiewicz E; Zaryczański J; Kursa MB; Szenborn L
    Vaccine; 2023 May; 41(21):3317-3327. PubMed ID: 37087396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study.
    Nygaard U; Holm M; Hartling UB; Glenthøj J; Schmidt LS; Nordly SB; Matthesen AT; von Linstow ML; Espenhain L
    Lancet Child Adolesc Health; 2022 Jul; 6(7):459-465. PubMed ID: 35526537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?
    Buchhorn R; Meyer C; Schulze-Forster K; Junker J; Heidecke H
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two pediatric cases of multisystem inflammatory-like syndrome following COVID-19 vaccination.
    Collignon C; Frachette C; Callot D; Pinhas Y; Bataille P; Bader-Meunier B; Chouchana L; Frémond ML; Belhadjer Z; Oualha M; Moulin F; Javouhey E; Belot A; Renolleau S
    Arch Pediatr; 2022 Nov; 29(8):620-623. PubMed ID: 36283888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.